{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T09:15:04Z","timestamp":1753521304511,"version":"3.38.0"},"reference-count":45,"publisher":"JLE","issue":"3","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.nephro.2005.03.002","type":"journal-article","created":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T14:26:35Z","timestamp":1117635995000},"page":"174-182","source":"Crossref","is-referenced-by-count":3,"title":["Le syndrome h\u00e9pator\u00e9nal chez le patient cirrhotique"],"prefix":"10.1684","volume":"1","author":[{"given":"St\u00e9phane","family":"Zaza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Bonny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Liaudet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2005.03.002_bib1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/gut.49.5.729","article-title":"The hepatorenal syndrome","volume":"49","author":"Dagher","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.nephro.2005.03.002_bib2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1440-1746.2002.02778.x","article-title":"Hepatorenal syndrome in patients with cirrhosis","volume":"17","author":"Moreau","year":"2002","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.nephro.2005.03.002_bib3","first-page":"11","article-title":"Update on hepatorenal syndrome","volume":"23","author":"Blaise","year":"2002","journal-title":"Nephrol."},{"key":"10.1016\/j.nephro.2005.03.002_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gines","year":"1993","journal-title":"Gastroenterol."},{"key":"10.1016\/j.nephro.2005.03.002_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatol."},{"key":"10.1016\/j.nephro.2005.03.002_bib6","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1681\/ASN.V1081833","article-title":"Hepatorenal syndrome","volume":"10","author":"Gines","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"issue":"Suppl.1","key":"10.1016\/j.nephro.2005.03.002_bib7","doi-asserted-by":"crossref","first-page":"63S","DOI":"10.1002\/lt.500060513","article-title":"Hepatorenal syndrome","volume":"6","author":"Cardenas","year":"2000","journal-title":"Liver Transpl."},{"key":"10.1016\/j.nephro.2005.03.002_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0750-7658(02)00851-1","article-title":"Hepatorenal syndrome: from physiopathology to treatment","volume":"22","author":"Aguillon","year":"2003","journal-title":"Ann. Fr. Anesth. Reanim."},{"key":"10.1016\/j.nephro.2005.03.002_bib9","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/hep.1840180520","article-title":"Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia","volume":"18","author":"Guarner","year":"1993","journal-title":"Hepatol."},{"key":"10.1016\/j.nephro.2005.03.002_bib10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","article-title":"Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis","volume":"339","author":"Martin","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.nephro.2005.03.002_bib11","doi-asserted-by":"crossref","first-page":"141S","DOI":"10.1016\/S0168-8278(00)80422-5","article-title":"Complications of cirrhosis. I. Portal hypertension","volume":"32","author":"Bosch","year":"2000","journal-title":"J. Hepatol."},{"key":"10.1016\/j.nephro.2005.03.002_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-2007-1007296","article-title":"Hepatorenal disorders: role of the sympathetic nervous system","volume":"14","author":"Henriksen","year":"1994","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.nephro.2005.03.002_bib13","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJM198212163072504","article-title":"Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis","volume":"307","author":"Bichet","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nephro.2005.03.002_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2007-1007295","article-title":"Hepatorenal disorders: role of the renin-angiotensin-aldosterone system","volume":"14","author":"Bernardi","year":"1994","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.nephro.2005.03.002_bib15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.7326\/0003-4819-96-4-413","article-title":"Role of vasopressin in abnormal water excretion in cirrhotic patients","volume":"96","author":"Bichet","year":"1982","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.nephro.2005.03.002_bib16","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1056\/NEJM199212173272502","article-title":"Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome","volume":"327","author":"Moore","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nephro.2005.03.002_bib17","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/jhep.2001.29200","article-title":"New challenge of hepatorenal syndrome: prevention and treatment","volume":"34","author":"Wong","year":"2001","journal-title":"Hepatol."},{"key":"10.1016\/j.nephro.2005.03.002_bib18","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.bjp.0704528","article-title":"Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites","volume":"135","author":"Lopez-Parra","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nephro.2005.03.002_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0168-8278(86)80154-4","article-title":"Urinary excretion of 6-keto-prostaglandin F1 alpha, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome)","volume":"3","author":"Rimola","year":"1986","journal-title":"J. Hepatol."},{"key":"10.1016\/j.nephro.2005.03.002_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00007890-199502150-00010","article-title":"Impact of pretransplant renal function on survival after liver transplantation","volume":"59","author":"Gonwa","year":"1995","journal-title":"Transplant."},{"key":"10.1016\/j.nephro.2005.03.002_bib21","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00007890-199102000-00030","article-title":"Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome--experience in 300 patients","volume":"51","author":"Gonwa","year":"1991","journal-title":"Transplant."},{"key":"10.1016\/j.nephro.2005.03.002_bib22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2003.09.019","article-title":"Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study","volume":"40","author":"Restuccia","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.nephro.2005.03.002_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.510270107","article-title":"Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion","volume":"27","author":"Guevara","year":"1998","journal-title":"Hepatol."},{"key":"10.1016\/j.nephro.2005.03.002_bib24","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/hep.510300430","article-title":"Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine","volume":"30","author":"Gulberg","year":"1999","journal-title":"Hepatol."},{"key":"10.1016\/j.nephro.2005.03.002_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","article-title":"Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome","volume":"33","author":"Uriz","year":"2000","journal-title":"J. Hepatol."},{"key":"10.1016\/j.nephro.2005.03.002_bib26","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study","volume":"122","author":"Moreau","year":"2002","journal-title":"Gastroenterol."},{"key":"10.1016\/j.nephro.2005.03.002_bib27","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatol."},{"key":"10.1016\/j.nephro.2005.03.002_bib28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","article-title":"Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study","volume":"36","author":"Duvoux","year":"2002","journal-title":"Hepatol."},{"key":"10.1016\/j.nephro.2005.03.002_bib29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.nephro.2005.03.002_bib30","first-page":"1753","article-title":"Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation","volume":"50","author":"Testino","year":"2003","journal-title":"Hepatogastroenterol."},{"key":"10.1016\/j.nephro.2005.03.002_bib31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/jhep.2003.50084","article-title":"Acute renal failure in patients with cirrhosis: perspectives in the age of MELD","volume":"37","author":"Moreau","year":"2003","journal-title":"Hepatol."},{"key":"10.1016\/j.nephro.2005.03.002_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/lv.2000.6355","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial","volume":"6","author":"Mitzner","year":"2000","journal-title":"Liver Transpl."},{"key":"10.1016\/j.nephro.2005.03.002_bib33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0016-5085(87)91007-9","article-title":"Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study","volume":"93","author":"Gines","year":"1987","journal-title":"Gastroenterol."},{"key":"10.1016\/j.nephro.2005.03.002_bib34","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0168-8278(97)80081-5","article-title":"Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis","volume":"27","author":"Salo","year":"1997","journal-title":"J. Hepatol."},{"key":"10.1016\/j.nephro.2005.03.002_bib35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1053\/gast.1997.v113.pm9247479","article-title":"Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis","volume":"113","author":"Ruiz-del-Arbol","year":"1997","journal-title":"Gastroenterol."},{"key":"10.1016\/j.nephro.2005.03.002_bib36","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/gut.46.5.588","article-title":"Is there still a need for albumin infusions to treat patients with liver disease?","volume":"46","author":"Gines","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.nephro.2005.03.002_bib37","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","author":"Gines","year":"1988","journal-title":"Gastroenterol."},{"key":"10.1016\/j.nephro.2005.03.002_bib38","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0016-5085(96)70068-9","article-title":"Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis","volume":"111","author":"Gines","year":"1996","journal-title":"Gastroenterol."},{"key":"10.1016\/j.nephro.2005.03.002_bib39","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.1840200619","article-title":"Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis","volume":"20","author":"Follo","year":"1994","journal-title":"Hepatol."},{"key":"10.1016\/j.nephro.2005.03.002_bib40","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.510270507","article-title":"Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality","volume":"27","author":"Navasa","year":"1998","journal-title":"Hepatol."},{"key":"10.1016\/j.nephro.2005.03.002_bib41","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hep.1840120416","article-title":"Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial","volume":"12","author":"Gines","year":"1990","journal-title":"Hepatol."},{"key":"10.1016\/j.nephro.2005.03.002_bib42","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(00)80201-9","article-title":"Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club","volume":"32","author":"Rimola","year":"2000","journal-title":"J. Hepatol."},{"key":"10.1016\/j.nephro.2005.03.002_bib43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nephro.2005.03.002_bib44","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1572-0241.2000.01772.x","article-title":"Upper gastrointestinal bleeding in patients with hepatic cirrhosis: clinical course and mortality prediction","volume":"95","author":"Afessa","year":"2000","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.nephro.2005.03.002_bib45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0016-5085(82)90129-9","article-title":"Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage","volume":"82","author":"Cabrera","year":"1982","journal-title":"Gastroenterol."}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725505000192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725505000192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2005.03.002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T13:43:23Z","timestamp":1741182203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725505000192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S1769725505000192"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2005.03.002","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}